• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用可溶性血管内皮生长因子受体-1预测子痫前期妊娠终止时间

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1.

作者信息

Tanaka Hiroaki, Tanaka Kayo, Takakura Sho, Enomoto Naosuke, Ikeda Tomoaki

机构信息

Department of Obstetrics and Gynecology, Mie University School of Medicine, Tsu, Japan.

出版信息

Front Med (Lausanne). 2022 Jun 20;9:900639. doi: 10.3389/fmed.2022.900639. eCollection 2022.

DOI:10.3389/fmed.2022.900639
PMID:35795634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9251116/
Abstract

BACKGROUND

The aim of this study was to determine the usefulness of placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) in predicting the time for pregnancy termination in pregnant women with known preeclampsia (PE) onset.

METHODS

Forty-four pregnant women diagnosed with PE (22 weeks 0 days to 33 weeks 6 days gestation) were included in this study. The levels of sFlt-1 and PlGF, and the sFlt-1/PlGF ratio were compared between the women that delivered in <24 h (T group) and those that delivered in more than 24 h (P group), and between women that delivered in <1 week (T group) and those that delivered in more than 1 week (P group). Cutoff values were calculated for the three markers that were the most significantly correlated with predicting pregnancy termination at <24 h and <1 week.

RESULTS

Among sFlt-1, PlGF, and sFlt-1/PlGF, sFlt-1 was the most significantly associated with the timing of pregnancy termination. sFlt-1 cutoff values of 8682.1 pg/ml (AUC 0.71; 95%Cl, 0.5191-0.9052) and 7,394.5 pg/ml (AUC 0.78; 0.78, 95%Cl, 0.6394-0.9206) for delivery in <24 h and delivery within 1 week, respectively, were important predictive values. The positive predictive value for delivery within 24 h was 43.9%, with a sensitivity of 72.3% and specificity of 69.0%, when sFlt-1 was <8,682 pg/ml. A sFlt-1 level of 7,394 pg/ml or greater would result in delivery within 1 week, with a positive predictive value of 67.2%; the sensitivity was 79.0% and specificity was 72.0%.

CONCLUSION

This study showed that sFlt-1 may be effective in predicting the timing of pregnancy termination. However, the number of cases was small and, thus, the results were not definitive. This finding should be researched further in order to predict the optimal timing of pregnancy termination in PE to reduce severe maternal complications.

摘要

背景

本研究的目的是确定胎盘生长因子(PlGF)和可溶性fms样酪氨酸激酶-1(sFlt-1)在预测已知先兆子痫(PE)发作的孕妇终止妊娠时间方面的作用。

方法

本研究纳入了44例诊断为PE的孕妇(妊娠22周0天至33周6天)。比较了在<24小时内分娩的妇女(T组)和在超过24小时内分娩的妇女(P组)之间,以及在<1周内分娩的妇女(T组)和在超过1周内分娩的妇女(P组)之间的sFlt-1和PlGF水平以及sFlt-1/PlGF比值。计算了与预测<24小时和<1周内终止妊娠最显著相关的三个标志物的临界值。

结果

在sFlt-1、PlGF和sFlt-1/PlGF中,sFlt-1与终止妊娠时间的相关性最显著。对于<24小时内分娩和1周内分娩,sFlt-1的临界值分别为8682.1 pg/ml(AUC 0.71;95%Cl,0.5191-0.9052)和7394.5 pg/ml(AUC 0.78;0.78,95%Cl,0.6394-0.9206),是重要的预测值。当sFlt-1<8682 pg/ml时,24小时内分娩的阳性预测值为43.9%,敏感性为72.3%,特异性为69.0%。sFlt-1水平≥7394 pg/ml会导致在1周内分娩,阳性预测值为67.2%;敏感性为79.0%,特异性为72.0%。

结论

本研究表明sFlt-1可能有效地预测终止妊娠的时间。然而,病例数较少,因此结果并不确定。这一发现应进一步研究,以预测PE患者终止妊娠的最佳时间,减少严重的孕产妇并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f821/9251116/c66dab801966/fmed-09-900639-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f821/9251116/b58e50765149/fmed-09-900639-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f821/9251116/11e71fc8ffd7/fmed-09-900639-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f821/9251116/ca105835c28a/fmed-09-900639-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f821/9251116/c66dab801966/fmed-09-900639-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f821/9251116/b58e50765149/fmed-09-900639-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f821/9251116/11e71fc8ffd7/fmed-09-900639-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f821/9251116/ca105835c28a/fmed-09-900639-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f821/9251116/c66dab801966/fmed-09-900639-g0004.jpg

相似文献

1
Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1.使用可溶性血管内皮生长因子受体-1预测子痫前期妊娠终止时间
Front Med (Lausanne). 2022 Jun 20;9:900639. doi: 10.3389/fmed.2022.900639. eCollection 2022.
2
The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.可溶性 Fms-样酪氨酸激酶-1(sFLT-1)和胎盘生长因子(PlGF)比值生物标志物在马来西亚吉隆坡中高危产妇预测子痫前期和不良妊娠结局中的可行性。
PLoS One. 2022 Mar 11;17(3):e0265080. doi: 10.1371/journal.pone.0265080. eCollection 2022.
3
Use of the sFlt-1/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?sFlt-1/PlGF 比值用于排除疑似疾病孕妇的子痫前期需要分娩。证据是否具有可重复性?
Clin Chem Lab Med. 2018 Jan 26;56(2):303-311. doi: 10.1515/cclm-2017-0443.
4
The Prognostic Value of Angiogenic Markers in Twin Pregnancies to Predict Delivery Due to Maternal Complications of Preeclampsia.血管生成标志物在双胎妊娠中对预测因子痫前期母体并发症而分娩的预后价值。
Hypertension. 2020 Jul;76(1):176-183. doi: 10.1161/HYPERTENSIONAHA.120.14957. Epub 2020 May 26.
5
Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria.可溶性fms样酪氨酸激酶-1(sFlt-1)/胎盘生长因子(PlGF)比值作为子痫前期、妊娠高血压和蛋白尿诊断工具的产前临床评估
Geburtshilfe Frauenheilkd. 2013 May;73(5):440-445. doi: 10.1055/s-0032-1328601.
6
Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study.评估胎盘生长因子和可溶性 fms 样酪氨酸激酶 1 在 36 孕周时的敏感性,以预测小于胎龄儿或晚发型子痫前期:一项前瞻性巢式病例对照研究。
BMC Pregnancy Childbirth. 2018 Aug 31;18(1):354. doi: 10.1186/s12884-018-1992-x.
7
The New Possibilities in Early Diagnosis of Preeclampsia by Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor in 16-20 Weeks Gestation.妊娠16 - 20周时可溶性fms样酪氨酸激酶-1和胎盘生长因子在子痫前期早期诊断中的新可能性
Lab Med. 2018 Mar 21;49(2):112-117. doi: 10.1093/labmed/lmx076.
8
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.sFlt-1:PlGF 比值在疑似子痫前期妇女中的预测价值。
N Engl J Med. 2016 Jan 7;374(1):13-22. doi: 10.1056/NEJMoa1414838.
9
Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation.预测 19-31 孕周采血后 4 周内子痫前期即将发生的可溶性 fms 样酪氨酸激酶 1/胎盘生长因子比值的血浆水平起始阈值。
Hypertens Res. 2013 Dec;36(12):1073-80. doi: 10.1038/hr.2013.95. Epub 2013 Aug 22.
10
[Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].孕中期母血清可溶性血管内皮生长因子受体1、胎盘生长因子及其比值在子痫前期预测中的价值
Zhonghua Fu Chan Ke Za Zhi. 2014 Jan;49(1):22-5.

本文引用的文献

1
Placental growth factor testing in the management of late preterm preeclampsia without severe features: a multicenter, randomized, controlled trial.胎盘生长因子检测在无严重特征的晚期早产儿子痫前期管理中的应用:一项多中心、随机、对照试验。
Am J Obstet Gynecol. 2021 Sep;225(3):308.e1-308.e14. doi: 10.1016/j.ajog.2021.03.044. Epub 2021 Apr 3.
2
Pregnancy-associated hemorrhagic stroke: A nationwide survey in Japan.妊娠相关出血性卒中:日本全国性调查
J Obstet Gynaecol Res. 2021 Jun;47(6):2066-2075. doi: 10.1111/jog.14786. Epub 2021 Apr 5.
3
Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine: A Real-World Study.
临床常规中 sFlt-1(可溶性 fms 样酪氨酸激酶 1)/PlGF(胎盘生长因子)比值预测子痫前期相关不良结局:一项真实世界研究。
Hypertension. 2021 Feb;77(2):461-471. doi: 10.1161/HYPERTENSIONAHA.120.15146. Epub 2020 Dec 7.
4
Prediction of adverse maternal outcomes of early severe preeclampsia.预测早期重度子痫前期的不良母婴结局。
Pregnancy Hypertens. 2020 Oct;22:144-150. doi: 10.1016/j.preghy.2020.09.009. Epub 2020 Sep 17.
5
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222.妊娠期高血压与子痫前期:ACOG 实践通报摘要,第 222 号。
Obstet Gynecol. 2020 Jun;135(6):1492-1495. doi: 10.1097/AOG.0000000000003892.
6
Impact of Hypertension and Preeclampsia Intervention Trial At Near Term-I (HYPITAT-I) on obstetric management and outcome in The Netherlands.高血压和子痫前期干预试验近中期-I(HYPITAT-I)对荷兰产科管理和结局的影响。
Ultrasound Obstet Gynecol. 2020 Jan;55(1):58-67. doi: 10.1002/uog.20417. Epub 2019 Sep 4.
7
Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia: INSPIRE.疑似子痫前期孕妇子痫前期/子痫预测的随机干预研究:INSPIRE。
Hypertension. 2019 Oct;74(4):983-990. doi: 10.1161/HYPERTENSIONAHA.119.12739. Epub 2019 Aug 12.
8
Decline in maternal death due to obstetric haemorrhage between 2010 and 2017 in Japan.2010 年至 2017 年期间日本因产科出血导致的孕产妇死亡人数下降。
Sci Rep. 2019 Jul 30;9(1):11026. doi: 10.1038/s41598-019-47378-z.
9
Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia.亚洲疑似子痫前期女性中 sFlt-1(可溶性 fms 样酪氨酸激酶 1)/PlGF(胎盘生长因子)比值的短期不良结局预测。
Hypertension. 2019 Jul;74(1):164-172. doi: 10.1161/HYPERTENSIONAHA.119.12760. Epub 2019 Jun 12.
10
Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients.将血管生成因子估测作为提示先兆子痫相关围产期发病率的指标:一项对住院患者的研究。
Hypertension. 2019 Apr;73(4):868-877. doi: 10.1161/HYPERTENSIONAHA.118.12205.